Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBITDA: 2023-2025

Historic EBITDA for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to -$6.2 million.

  • Incannex Healthcare's EBITDA fell 21.57% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.8 million, marking a year-over-year decrease of 113.48%. This contributed to the annual value of -$46.7 million for FY2025, which is 151.94% down from last year.
  • Incannex Healthcare's EBITDA amounted to -$6.2 million in Q3 2025, which was up 80.16% from -$31.3 million recorded in Q2 2025.
  • Incannex Healthcare's 5-year EBITDA high stood at -$1.2 million for Q3 2023, and its period low was -$31.3 million during Q2 2025.
  • Over the past 3 years, Incannex Healthcare's median EBITDA value was -$6.1 million (recorded in 2024), while the average stood at -$7.9 million.
  • Data for Incannex Healthcare's EBITDA shows a peak YoY increase of 40.80% (in 2025) and a maximum YoY decrease of 409.45% (in 2025) over the last 5 years.
  • Incannex Healthcare's EBITDA (Quarterly) stood at -$4.3 million in 2023, then plummeted by 46.22% to -$6.3 million in 2024, then declined by 21.57% to -$6.2 million in 2025.
  • Its last three reported values are -$6.2 million in Q3 2025, -$31.3 million for Q2 2025, and -$4.1 million during Q1 2025.